Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 880

1.

DTC advertising harms patients and should be tightly regulated.

Lurie P.

J Law Med Ethics. 2009 Fall;37(3):444-50, 396. doi: 10.1111/j.1748-720X.2009.00405.x.

PMID:
19723255
2.

The new drug marketing: a consumer protection perspective.

Woodward D.

Food Drug Law J. 1996;51(4):637-50. No abstract available.

PMID:
11797733
3.

The educational potential of direct-to-consumer prescription drug advertising.

Kaphingst KA, DeJong W.

Health Aff (Millwood). 2004 Jul-Aug;23(4):143-50.

4.

Direct-to-consumer drug marketing: public service or disservice?

Berger JT, Kark P, Rosner F, Packer S, Bennett AJ.

Mt Sinai J Med. 2001 May;68(3):197-202.

PMID:
11373692
5.

Ensuring that consumers receive appropriate information from drug ads: what is the FDA's role?

Waxman HA.

Health Aff (Millwood). 2004 Jan-Jun;Suppl Web Exclusives:W4-256-8.

6.

Regulation of prescription drug promotion: direct-to-consumer advertising.

Baylor-Henry M, Drezin NA.

Clin Ther. 1998;20 Suppl C:C86-95. Review.

PMID:
9915094
7.

Recent developments in direct consumer advertising of attention disorder stimulants and creating limits to withstand constitutional scrutiny.

Strawn MN.

J Contemp Health Law Policy. 2003 Spring;19(2):495-520. Review. No abstract available.

PMID:
14748255
8.

Examining the FDA's oversight of direct-to-consumer advertising.

Gahart MT, Duhamel LM, Dievler A, Price R.

Health Aff (Millwood). 2003 Jan-Jun;Suppl Web Exclusives:W3-120-3.

9.

Efforts to ban direct-to-consumer advertising in New Zealand: a call to action.

Hoffman JR, Cooper RJ.

Br J Gen Pract. 2003 Apr;53(489):267-9. No abstract available.

10.

Direct-to-consumer advertising: for better profits or for better health?

Hoen E.

Am J Health Syst Pharm. 1998 Mar 15;55(6):594-7. No abstract available.

PMID:
9544337
11.

Turning point or tipping point: new FDA draft guidances and the future of DTC advertising.

Pitts PJ.

Health Aff (Millwood). 2004 Jan-Jun;Suppl Web Exclusives:W4-259-61.

12.

FDA considers tightening regulations for direct-to-consumer advertising.

Vastag B.

J Natl Cancer Inst. 2005 Dec 21;97(24):1806-7. No abstract available.

13.

What nurse practitioners should know about direct-to-consumer advertising of prescription medications.

Viale PH.

J Am Acad Nurse Pract. 2003 Jul;15(7):297-304. Review.

PMID:
12929250
14.

Patient autonomy and the regulation of direct-to-consumer advertising.

Zachry WM 3rd, Ginsburg DB.

Clin Ther. 2001 Dec;23(12):2024-37; discussion 2022-3. Review.

PMID:
11813936
15.

Claim substantiation in the health care industry.

Fergenson PE.

Hosp Mater Manage Q. 1992 May;13(4):20-6. No abstract available.

PMID:
10117377
16.

The role of direct-to-consumer advertising.

Navarro RP.

Manag Care Interface. 1998 Nov;11(11):79-80, 82. No abstract available.

PMID:
10187419
17.

Direct-to-consumer prescription drug advertising.

Terzian TV.

Am J Law Med. 1999;25(1):149-67. Review. No abstract available.

PMID:
10207573
18.

Direct-to-consumer promotion: an industry perspective.

Pines WL.

Clin Ther. 1998;20 Suppl C:C96-103. Review.

PMID:
9915095
19.

US aims to tighten rules on direct-to-consumer drug ads.

Vastag B.

Nat Biotechnol. 2007 Mar;25(3):267. Epub 2007 Mar 1. No abstract available.

PMID:
17344868
20.

Reforming direct-to-consumer advertising.

Liang BA, Mackey T.

Nat Biotechnol. 2011 May;29(5):397-400. doi: 10.1038/nbt.1865. No abstract available.

PMID:
21552236
Items per page

Supplemental Content

Write to the Help Desk